Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in escherichia coli

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Upadhyay, Arun K ^a   Murmu, Aruna ^a   Singh, Anupam ^a   Panda, Amulya K ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; HUMAN GROWTH HORMONE; PROTEINASE K; UREA;

ALPHA HELIX; ARTICLE; BETA SHEET; BINDING AFFINITY; CELL INCLUSION; CONTROLLED STUDY; ESCHERICHIA COLI; HYDROPHOBICITY; MOLECULAR INTERACTION; MOLECULAR SIZE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INDUCTION; SOLUBILIZATION;

AMYLOID; ASPARAGINASE; BACTERIAL PROTEINS; ENDOPEPTIDASE K; ESCHERICHIA COLI; GROWTH HORMONE; HUMANS; INCLUSION BODIES; KINETICS; PROTEIN BINDING; PROTEOLYSIS; RECOMBINANT PROTEINS; SOLUBILITY; TIME FACTORS;

ESCHERICHIA COLI;

EID: 84859055238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033951     Document Type: Article

References (44)

1. Fahnert B, Lilie H, Neubauer P, (2004) Inclusion bodies: formation and utilization. Adv Biochem Eng/Biotechnol 89: 93-142.
2. Villaverde A, Carrió MM, (2003) Protein aggregation in recombinant bacteria: biological role of inclusion bodies. Biotechnol Lett 25: 85-95.
3. Georgiou G, Valax P, (1999) Isolating inclusion bodies from bacteria. Methods Enzymol 309: 48-58.
4. Taylor G, Hoare M, Gray DR, Marston FAO, (1986) Size and density of protein inclusion bodies. Bio/Technology 4: 553-557.
5. Ventura S, (2005) Sequence determinants of protein aggregation: tools to increase protein solubility. Microb Cell Fact 4: 11.
6. Rinas U, Bailey JE, (1992) Protein compositional analysis of inclusion bodies produced in recombinant Escherichia coli. Appl Microbiol Biotechnol 37: 609-614.
7. Rudolph R, (1996) Successful protein folding at industrial scale. Protein engineering: principles and practice pp. 293-298 John Wiley and sons: New York.
8. Vallejo LF, Rinas U, (2004) Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb Cell Fact 3: 11.
9. Panda AK, (2003) Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli. Adv Biochem Eng/Biotechnol 85: 43-93.
10. Fink AL, (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des 3: R9-23.
11. Ventura S, Villaverde A, (2006) Protein quality in bacterial inclusion bodies. Trends Biotechnol 24: 179-185.
12. Przybycien TM, Dunn JP, Valax P, Georgiou G, (1994) Secondary structure characterization of β-lactamase inclusion bodies. Protein Eng 7: 131-136.
13. Oberg K, Chrunyk BA, Wetzel R, Fink AL, (1994) Native-like secondary structure in interleukin-1 β inclusion bodies by attenuated total reflectance FTIR. Biochemistry 33: 2628-2634.
14. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S, (2005) Amyloid-like properties of bacterial inclusion bodies. J Mol Biol 347: 1025-1037.
15. Ignatova Z, Krishnan B, Bombardier JP, Marcelino AM, Hong J, et al. (2007) From the test tube to the cell: exploring the folding and aggregation of a β-Clam protein. Biopolymers 88: 157-163.
16. Morell M, Bravo R, Espargaro A, Sisquella X, Aviles FX, et al. (2008) Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim Biophys Acta 1783: 1815-1825.
17. Doglia SM, Ami D, Natalello A, Gatti-Lafranconi P, Lotti M, (2008) Fourier transform infrared spectroscopy analysis of the conformational quality of recombinant proteins within inclusion bodies. Biotechnol J 3: 193-201.
18. Wang L, Maji SK, Sawaya MR, Eisenberg D, Riek R, (2008) Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol 6: e195.
19. Speed MA, Wang DIC, King J, (1996) Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat Biotechnol 14: 1283-1287.
20. Margreiter G, Messner P, Caldwell KD, Bayer K, (2008) Size characterization of inclusion bodies by sedimentation field-flow fractionation. J Biotechnol 138: 67-73.
21. Margreiter G, Schwanninger M, Bayer K, Obinger C, (2008) Impact of different cultivation and induction regimes on the structure of cytosolic inclusion bodies of TEM1-β-lactamase. Biotechnol J 3: 1245-1255.
22. Carrio MM, Villaverde A, (2001) Protein aggregation as bacterial inclusion bodies is reversible. FEBS Lett 489: 29-33.
23. Carrio MM, Cubarsi R, Villaverde A, (2000) Fine architecture of bacterial inclusion bodies. FEBS Lett 471: 7-11.
24. Ami D, Natalello A, Gatti-Lafranconi P, Lotti M, Doglia SM, (2005) Kinetics of inclusion body formation studied in intact cells by FT-IR spectroscopy. FEBS Letters 579: 3433-3436.
25. Garcia-Fruitos E, Carrio MM, Aris A, Villaverde A, (2005) Folding of a misfolding-prone β-galactosidase in absence of DnaK. Biotechnol Bioeng 90: 869-875.
26. Worrall DM, Goss NH, (1989) The formation of biologically active β- galactosidase inclusion bodies in Escherichia coli. Aust J Biotechnol 3: 28-32.
27. Garcia-Fruitos E, Vazquez E, Diez-Gil C, Corchero JL, Seras-Franzoso J, et al. (2012) Bacterial inclusion bodies: making gold from waste. Trends Biotechnol 30: 65-70.
28. Peternal S, Komel R, (2011) Active protein aggregates produced in Escherichia coli. Int J Mol Sci 12: 8275-8287.
29. Jevsevar S, Gaberc-Porekar V, Fonda I, Podobnik B, Grdadolnik J, et al. (2005) Production of non-classical inclusion bodies from which correctly folded protein can be extracted. Biotechnol Prog 21: 632-639.
30. Peternal S, Grdadolnik J, Gaberc-Porekar V, Komel R, (2008) Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Fact 7: 34.
31. Carvajal P, Gibert J, Campos N, Lopera O, Barbera E, et al. (2011) Activity of maize transglutaminase over expressed in Escherichia coli inclusion bodies: An alternative to protein refolding. Biotechnol Prog 27: 232-240.
32. Patra AK, Gahlay GK, Reddy BV, Gupta SK, Panda AK, (2000) Refolding, structural transition and spermatozoa-binding of recombinant bonnet monkey (Macaca radiata) zona pellucida glycoprotein-C expressed in Escherichia coli. Eur J Biochem 26: 7075-7081.
33. Umetsu M, Tsumoto K, Nitta S, Adschiri T, Ejima D, et al. (2005) Nondenaturing solubilization of β2 microglobulin from inclusion bodies by L-arginine. Biochem Biophys Res Commun 328: 189-197.
34. Singh SM, Panda AK, (2005) Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 99: 303-310.
35. Kopito RR, (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10: 524-530.
36. DeLellis RA, Glenner GG, Ram JS, (1968) Histochemical observations on amyloid with reference to polarization microscopy. J Histochem Cytochem 16: 663-665.
37. Glenner GG, Eanes ED, Page DL, (1972) The relation of the properties of Congo red-stained amyloid fibrils to the β-conformation. J Histochem Cytochem 20: 821-826.
38. Cooper JH, (1974) Selective amyloid staining as a function of amyloid composition and structure. Histochemical analysis of the alkaline Congo red, standardized toluidine blue, and iodine methods. Lab Invest 31: 232-238.
39. LeVine H III, (1997) Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer β (1-40) amyloid fibrils. Arch Biochem Biophys 342: 306-316.
40. Naiki H, Higuchi K, Hosokaw M, Takeda T, (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 177: 244-249.
41. Salnikova MS, Middaugh CR, Rytting JH, (2008) Stability of lyophilized human growth hormone. Int J Pharm 358: 108-113.
42. Ward KR, Adams GD, Alpar HO, Irwin WJ, (1999) Protection of the enzyme L-asparaginase during lyophilisation-a molecular modeling approach to predict required level of lyoprotectant. Int J Pharm 187: 153-162.
43. Singh SM, Sharma A, Upadhyay AK, Singh A, Garg LC, et al. (2012) Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form. Protein Expr Purif 81: 75-82.
44. Wriston JC Jr, (1985) Asparaginase. Methods Enzymol 113: 608-618.